Ronald Devore, MD
Otolaryngology · Springboro, OHNPI 1619078201
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,013 of the $2,713 with a category attached, or 74.2%. 9 manufacturers reported payments, led by Acclarent, Inc at 48.8% of the total. Reporting peaked in 2019 at $1,344 and has fallen 80.6% since, to $261 in 2025.
Across 44 payments — averaging $61.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$1K
- Medical Device Business Services, Inc.$700
- Intersect ENT, Inc.$181
- Aerin Medical Inc.$144
- Medtronic$116
- Stryker$112
- plus $136 from 3 others
Across 1 payment — averaging $1800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acclarent, Inc$2K
What the payments were for
- Consulting fees$70026%
- Food & beverage$2,01374%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 27 | $1,324 |
| Medical Device Business Services, Inc. | 3 | $700 |
| Intersect ENT, Inc. | 4 | $181 |
| Aerin Medical Inc. | 1 | $144 |
| Medtronic | 1 | $116 |
| Stryker | 5 | $112 |
| Integra Lifesciences Corporation | 1 | $100 |
| AbbVie | 1 | $19 |
| Sanofi | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,713 in reported general payments places this provider in the 70th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Springboro
- Raj SindwaniCleveland$598K
- Mark MehleCleveland$403K
- Troy WoodardCleveland$392K
- Oliver AdunkaColumbus$338K
- Subinoy DasColumbus$142K
- Sanjeet RangarajanCleveland$113K
- Sumit BapnaDublin$95K
- Boris KaranfilovDublin$82K
- Alexander DonathCincinnati$64K
- Rod RezaeeCleveland$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.